EFFECTS OF AMINOGLYCOSIDE, BETA-LACTAM AND QUINOLONE ANTIBIOTICS ON PSEUDOMONAS-AERUGINOSA ENZYMES

被引:0
作者
HOSTACKA, A
MAJTAN, V
HYBENOVA, D
机构
关键词
SUB-MICS OF ANTIBIOTICS; PSEUDOMONAS AERUGINOSA; PHOSPHOLIPASE C; ELASTASE; PROTEINASE;
D O I
暂无
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Aminoglycoside (tobramycin, netilmicin, amikacin), beta-lactam (ceftazidime, imipenem, azlocillin), as well as quinolone (ciprofloxacin, ofloxacin, pefloxacin) antibiotics in all sub-MICs, but mainly at the level of 1/4 of the MICs, significantly decreased P. aeruginosa phospholipase C activity. Netilmicin, imipenem and ciprofloxacin most strongly reduced the tested activity at this level of antibiotic concentrations. 1/4 of the MICs of the studied antibiotics were also the most effective in suppression of elastase activity, but the degree of this inhibition was not as high as that for phospholipase C activity. Tobramycin and imipenem reduced this activity in all sub-MICs. Ofloxacin (1/4 of the MIG) caused the highest suppression of elastase activity. Proteinase activity was decreased after treatment with all tested sub-MICs of tobramycin and imipenem. The most significant suppression of activity was achieved by the effect of ciprofloxacin (1/4 of the MIC).
引用
收藏
页码:819 / 824
页数:6
相关论文
共 50 条
  • [21] In Vitro Activity of the Ultrabroad-Spectrum Beta-Lactamase Inhibitor QPX7728 in Combination with Multiple Beta-Lactam Antibiotics against Pseudomonas aeruginosa
    Lomovskaya, Olga
    Rubio-Aparicio, Debora
    Nelson, Kirk
    Sun, Dongxu
    Tsivkovski, Ruslan
    Castanheira, Mariana
    Lindley, Jill
    Loutit, Jeffery
    Dudley, Michael
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2021, 65 (06)
  • [22] Bactericidal activity of cefpirome-aminoglycoside combinations against Pseudomonas aeruginosa strains showing intermediate susceptibility to cefpirome and various beta-lactam resistance mechanisms.
    Canis, F
    Cavallo, JD
    Husson, MO
    PATHOLOGIE BIOLOGIE, 1997, 45 (05): : 420 - 423
  • [23] Epidemiological study of variations in beta-lactam antibiotic susceptibility of Pseudomonas aeruginosa in two intensive care units
    Cailleaux, V
    Mulin, B
    Capellier, G
    Julliot, MC
    Thouverez, M
    Talon, D
    JOURNAL OF HOSPITAL INFECTION, 1997, 37 (03) : 217 - 224
  • [24] High prevalence of blaVEB, blaGES and blaPER genes in beta-lactam resistant clinical isolates of Pseudomonas aeruginosa
    Haghighi, Saboura
    Goli, Hamid Reza
    AIMS MICROBIOLOGY, 2022, 8 (02): : 153 - 166
  • [25] The Mechanism of Resistance of Pseudomonas Aeruginosa toβ-lactam Antibiotics and Clinical Significance
    宋建新
    阮秋蓉
    齐俊英
    高美英
    王以光
    华中科技大学学报(医学英德文版), 2002, (04) : 339 - 342
  • [26] Effect of β-lactam antibiotics on the in vitro development of resistance in Pseudomonas aeruginosa
    Carsenti-Etesse, H
    Cavallo, JD
    Roger, PM
    Ziha-Zarifi, I
    Plesiat, P
    Garrabe, E
    Dellamonica, P
    CLINICAL MICROBIOLOGY AND INFECTION, 2001, 7 (03) : 144 - 151
  • [27] AMINOGLYCOSIDE RESISTANCE IN PSEUDOMONAS-AERUGINOSA DUE TO OUTER-MEMBRANE STABILIZATION
    YONEYAMA, H
    SATO, K
    NAKAE, T
    CHEMOTHERAPY, 1991, 37 (04) : 239 - 245
  • [28] The mechanism of resistance of pseudomonas aeruginosa to β-lactam antibiotics and clinical significance
    Jianxin Song
    Qiurong Ruan
    Junying Qi
    Meiying Gao
    Yiguang Wang
    Current Medical Science, 2002, 22 (4) : 339 - 342
  • [29] Bacteriophage Therapy on an In Vitro Wound Model and Synergistic Effects in Combination with Beta-Lactam Antibiotics
    Santamaria-Corral, Guillermo
    Aguilera-Correa, John Jairo
    Esteban, Jaime
    Garcia-Quintanilla, Meritxell
    ANTIBIOTICS-BASEL, 2024, 13 (09):
  • [30] Newer Beta-lactam Antibiotics: Doripenem, Ceftobiprole, Ceftaroline, and Cefepime
    Bazan, Jose A.
    Martin, Stanley I.
    Kaye, Kenneth M.
    MEDICAL CLINICS OF NORTH AMERICA, 2011, 95 (04) : 743 - +